Cannabis Bioscience International Holdings (CBIH) Return on Equity (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Return on Equity across 4 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Equity for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Equity came in at 0.0% for Q1 2026 at Cannabis Bioscience International Holdings, down from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.02% in Q3 2023 to a low of 0.0% in Q1 2025.
• The 4-year median for Return on Equity is 0.0% (2024), against an average of 0.01%.
• Across the five-year window, Return on Equity fell 1 bps in 2024 and changed 0 bps in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Return on Equity stood at 0.01% in 2023, then sank by 71 bps to 0.0% in 2024, then soared by 36 bps to 0.0% in 2025, then declined by 15 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.